News from feldan therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 27, 2018, 08:30 ET Feldan Therapeutics Announces Additional Investment in Series A

QUÉBEC CITY, Nov. 27, 2018 /CNW Telbec/ - Feldan Therapeutics (hereafter "Feldan"), a preclinical biotechnology company specialized in the intracellular delivery of therapeutic proteins and peptides, ...


Oct 12, 2018, 08:30 ET University of Iowa and Feldan Therapeutics awarded grant by the National Institutes of Health

QUEBEC CITY, Oct. 12, 2018 /CNW Telbec/ - David Guay, Research Director of Feldan Therapeutics (hereafter "Feldan") announced that his collaborator, Dr. Paul McCray from the University of Iowa Carver ...


Sep 18, 2018, 08:30 ET Feldan Therapeutics Raises $12.5 Millions in Series A Financing Round

QUÉBEC CITY, Sept. 18, 2018 /CNW Telbec/ - Feldan Therapeutics (hereafter "Feldan") has announced the closing of a $12.5 millions Series A financing round led by GC (parent company of GC Pharma),...


Jun 27, 2018, 08:30 ET GC LabCell and Feldan Therapeutics announce license agreement to develop next-generation NK cells for immunotherapy using Feldan Shuttle technology

SEOUL, South Korea and QUÉBEC CITY, June 27, 2018 /CNW Telbec/ - GC LabCell (hereafter "GCLC") and Feldan Therapeutics (hereafter "Feldan") announced an agreement today granting GCLC exclusive rights ...


May 29, 2018, 09:57 ET Feldan Therapeutics awarded US Patent for the second generation of its Feldan Shuttle platform

QUEBEC CITY, May 29, 2018 /CNW Telbec/ - Feldan Therapeutics, Inc. announced today the issuance of a new patent related to the refinement of the Feldan Shuttle platform. This technology, a...


Jan 15, 2018, 09:30 ET Feldan Therapeutics and Green Cross LabCell Announce Start of Joint collaboration

Combined Feldan Shuttle and Green Cross LabCell NK cell technologies will be used to develop hyperactive NK cell immunotherapies QUEBEC, Jan. 15, 2018 /CNW Telbec/ - Green Cross LabCell, involved in...


Aug 22, 2017, 10:04 ET Feldan Therapeutics Announces Issuance of First Patent for its Peptide-Based Protein Delivery Technology, the Feldan Shuttle

QUEBEC CITY, Aug. 22, 2017 /CNW Telbec/ - Feldan Therapeutics, Inc. today announced the issuance of its first patent covering the company's technology, the Feldan Shuttle platform. The United States...


May 09, 2017, 08:19 ET Feldan Therapeutics and Elasmogen Announce Research Agreement with Amgen to Develop Intracellular Biologics

Combined Feldan Shuttle and Elasmogen soloMER technology will be used to deliver intracellular candidates for two targets ABERDEEN, Scotland and QUEBEC CITY, May 9, 2017 /CNW Telbec/ - Elasmogen Ltd, ...